[Physiopathology and treatment of metabolic changes in transintestinal urinary diversions].
The use of intestinal segments in the urinary tract can cause metabolic changes that depend on the intestinal segment utilized. The severity of these changes basically depends on the area of the intestinal mucosa in contact with urine, the duration of exposure to urine and renal function. The length of time the intestinal mucosa is in contact with urine largely depends on the surgical technique employed. It is longer for the reservoirs, intestinal neobladders and ureterosigmoidostomies than for the intestinal conduits with cutaneous urinary diversion and therefore carry a higher incidence of metabolic changes. Jejunal urinary diversion causes metabolic acidosis with hypochloremia, hyponatremia, hyperpotassemia, azotemia and dehydration in at least 50% of the cases. Ileal and colonic urinary diversion can cause metabolic acidosis, although the incidence is significantly less. Acidosis presents with hyperchloremia, hyperammonemia, hypersulfatemia, increased osmolality and uremia with normal creatininemia and a tendency to develop hypocalcemia, hypophosphoremia and hypomagnesemia. Recent studies performed in our service show that acidosis is basically due to the secretion of sodium bicarbonate by the intestinal segment used in the urinary tract, which causes water-salt depletion that is compensated by secondary hyperaldosteronism. Mild chronic acidosis is neutralized via the respiratory system and by the bone buffers, which leads to bone remodelling manifested by the significant increase of serum alkaline phosphatase levels and increased calciuria. These calcium phosphate changes, although statistically significant, do not appear to be important since they were not accompanied by changes of serum PTH levels, 25 and 1-25-cholecalciferol. Nicotinic acid as inhibitor of cyclic AMP synthesis failed to correct metabolic acidosis in the patients with transileal diversion.
Martínez-Piñeiro
L
L
Hospital La Paz, Servicio de Urología, Madrid, España.
Mateos Antón
F
F
Martínez-Piñeiro
J A
JA
D000138:Acidosis / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy; D001693:Biological Transport, Active; D002118:Calcium / Q000378:metabolism; D003106:Colon / Q000378:metabolism / Q000601:surgery; D000242:Cyclic AMP / Q000378:metabolism; D004573:Electrolytes / Q000378:metabolism; D005753:Gastric Mucosa / Q000378:metabolism; D006801:Humans; D007082:Ileum / Q000378:metabolism / Q000601:surgery; D007413:Intestinal Mucosa / Q000378:metabolism; D007422:Intestines / Q000601:surgery; D009525:Niacin / Q000378:metabolism; D010758:Phosphorus / Q000378:metabolism; D013270:Stomach / Q000601:surgery; D014547:Urinary Diversion / Q000009:adverse effects* / Q000379:methods
D004573:Electrolytes; D009525:Niacin; D010758:Phosphorus; D000242:Cyclic AMP; D002118:Calcium
Fisiopatología y tratamiento de las alteraciones metabólicas en las derivaciones urinarias transintestinales.